ICCV 2026: 20. International Conference on Cancer Vaccine

October 28-29, 2026 in Lisbon, Portugal

HYBRID

Conference Code: 26PTLI10ICCV002

Submit Your Paper Author Registration Listener Registration

The International Research Conference Aims and Objectives

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.

International Conference on Cancer Vaccine aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Cancer Vaccine. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Cancer Vaccine.

Call for Contributions

Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Cancer Vaccine are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.

Guidelines for Authors

Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.

Please refer to the Paper Submission Guideline, Abstract Submission Guideline and Author Information before submitting your paper.

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the Open Science Index, Google Scholar, Semantic Scholar, Zenedo, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.

Special Journal Issues

20. International Conference on Cancer Vaccine has teamed up with the Special Journal Issue on Cancer Vaccine. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.

Conference Sponsor and Exhibitor Opportunities

The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Application Forms

Selected Papers

Synthesis of Highly Stable Near-Infrared FAPbI3 Perovskite Doped with 5-AVA and Its Applications in Near-Infrared Light-Emitting Diodes for Bioimaging
Nasrud Din, Rai Muhammad Dawood Sultan, Fawad Saeed, Sajid Hussain, Premkumar Sellan, Qasim Khan, Wei Lei
Concepts of the COVID-19 Pandemic and the Implications of Vaccines for Health Security in Nigeria and Diasporas
Wisdom Robert Duruji
The Role of Mobile Technology in Surveillance of Adverse Events Following Immunization during New Vaccines Introduction in Cameroon: A Cross-Sectional Study
A. A. Njoh, S. T. Ndoula, A. Adidja, G. N. Menan, A. Mengue, E. Mboke, H. B. Bachir, S. C. Nchinjoh, L. Adisso, Y. Saidu, L. Cleenewerck de Kiev
Relationship between Iron-Related Parameters and Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis in Obese Children
Mustafa M. Donma, Orkide Donma, Savas Guzel
Assessment of the Efficacy of Oral Vaccination of Wild Canids and Stray Dogs against Rabies in Azerbaijan
E. N. Hasanov, K. Y. Yusifova, M. A. Ali
Automated 3D Segmentation System for Detecting Tumor and Its Heterogeneity in Patients with High Grade Ovarian Epithelial Cancer
D. A. Binas, M. Konidari, C. Bourgioti, L. Angela Moulopoulou, T. L. Economopoulos, G. K. Matsopoulos
A Recommendation to Oncologists for Cancer Treatment by Immunotherapy: Quantitative and Qualitative Analysis
Mandana Kariminejad, Ali Ghaffari
Comparison of the Use of Vaccines or Drugs against Parasitic Diseases
H. Al-Khalaifa, A. Al-Nasser
A Dose Distribution Approach Using Monte Carlo Simulation in Dosimetric Accuracy Calculation for Treating the Lung Tumor
Md Abdullah Al Mashud, M. Tariquzzaman, M. Jahangir Alam, Tapan Kumar Godder, M. Mahbubur Rahman
Identification of Promiscuous Epitopes for Cellular Immune Responses in the Major Antigenic Protein Rv3873 Encoded by Region of Difference 1 of Mycobacterium tuberculosis
Abu Salim Mustafa
Grade and Maximum Tumor Dimension as Determinants of Lymphadenectomy in Patients with Endometrioid Endometrial Cancer (EEC)
Ali A. Bazzi, Ameer Hamza, Riley O’Hara, Kimberly Kado, Karen H. Hagglund, Lamia Fathallah, Robert T. Morris
Dosimetric Analysis of Intensity Modulated Radiotherapy versus 3D Conformal Radiotherapy in Adult Primary Brain Tumors: Regional Cancer Centre, India
Ravi Kiran Pothamsetty, Radha Rani Ghosh, Baby Paul Thaliath
Computer Aided Diagnostic System for Detection and Classification of a Brain Tumor through MRI Using Level Set Based Segmentation Technique and ANN Classifier
Atanu K Samanta, Asim Ali Khan
Displaying of GnRH Peptides on Bacteriophage T7 and Its Immunogenicity in Mice Model
Hai Xu, Yiwei Wang, Xi Bao, Bihua Deng, Pengcheng Li, Yu Lu
Antibody-Conjugated Nontoxic Arginine-Doped Fe3O4 Nanoparticles for Magnetic Circulating Tumor Cells Separation
F. Kashanian, M. M. Masoudi, A. Akbari, A. Shamloo, M. R. Zand, S. S. Salehi

Conference venue information will be released soon.

Cancer Vaccine
Personalized Cancer Vaccine
Immunotherapy
Oncology
Tumor Immunology
Cancer Treatment
Vaccine Development
Clinical Trials
Personalized Medicine
Cancer Research
Immunization
Tumor Antigens
Cancer Prevention
Vaccine Efficacy
Cancer Immunoprevention
Cancer Immunotherapy
Therapeutic Vaccines
Prophylactic Vaccines
Cancer Biology
Vaccine Technology
Immune Response
Checkpoint Inhibitors
Cancer Vaccination
Tumor Microenvironment
Neoantigens
Immunogenicity
Antigen Presentation
Vaccine Platforms
Cancer Metastasis
Adjuvants
Cytotoxic T Cells

Abstracts/Full-Text Paper Submission Deadline		November 05, 2025
Notification of Acceptance/Rejection		December 08, 2025
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline		September 30, 2026
Conference Dates		October 28-29, 2026